BioNTech stock is a "Strong Buy", driven by positive phase 3 data for gotistobart in 2nd-line squamous NSCLC patients. Read ...
Two years after this, Sakaguchi was able to link these discoveries. He proved that the Foxp3 gene governs the development of ...
Discover expert strategies for selecting optimal labels for single particle tracking in super-resolution microscopy ...
The race to understand the brain has just crossed a new threshold, with a supercomputer-driven model that behaves less like a ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced the planned initiation of an investigator-sponsored study (IST) by City of Hope, a U.S. cancer ...
Daiichi Sankyo continues to advance its pipeline, offering positive catalysts over the next year. Click here to read why ...
The CEOs of MTN, Vodacom, Telkom and Blu Label Unlimited earned a combined R224.9 million in the most recent fiscal year.